Tag Archives: VTR

Hot Blue Chip Stocks To Own For 2022

No matter how many warnings experts issue regarding penny stocks, people invariably find their way into this speculative arena. And that issue has become even more prominent thanks to mobile trading apps like Robinhood (NASDAQ:HOOD). With the ability to wager on the full spectrum of investment vehicles right at your fingertips, Robinhood is somewhat of a mixed bag.

On the one hand, let’s at least give credit where it’s due. Prior to the novel coronavirus pandemic, financial analysts bemoaned that younger people were investing at a lower rate than prior generations at their age milestones. Suddenly, with extra time on their hands and government stimulus checks in the mail, many folks started making up for lost time. However, quite a few did so through penny stocks.

That’s not to say that this segment of the market is inherently a poor choice. Many of today’s blue chips once started off as little more than a dream, with share prices reflecting this risk profile. But with patience and truckloads of good fortune, you can make a killing with penny stocks.

Hot Blue Chip Stocks To Own For 2022: PIMCO Strategic Income Fund, Inc.(RCS)

PIMCO Strategic Global Government Fund, Inc. (the Fund) is a closed-end bond fund. The Fund invests primarily in a portfolio of investment grade fixed-income securities of the United States and other countries. The Fund invests, under normal circumstances, at least 80% of its net assets plus borrowings for investment purposes in government securities, which include bonds issued or guaranteed by the United States or foreign governments, by their agencies, authorities or instrumentalities, or by supranational entities, and synthetic instruments.

Government securities also include mortgage-backed securities issued or guaranteed by certain United States Government agencies and government-sponsored enterprises, including Federal Home Loan Mortgage Corporation (Freddie Mac), Federal National Mortgage Association (Fannie Mae) and Government National Mortgage Association (Ginnie Mae), which may or may not be backed by the full faith and credit of the United States Government. The Fund also invests up to 20% of its total assets in non-investment grade securities regardless of the issuer, including corporate, mortgage-backed and asset-backed securities. Pacific Investment Management Company LLC is the Fund’s investment adviser.

Advisors’ Opinion:

  • [By Alexander Bird]

    Two funds we like are the Strategic Global Government Fund Inc. (NYSE: RCS), which pays a handsome 7.8% dividend yield, and Oxford Lane Capital Corp. (NASDAQ: OXLC), which pays a massive 16.46% yield.

Hot Blue Chip Stocks To Own For 2022: Truett-Hurst, Inc.(THST)

Truett-Hurst, Inc., incorporated on December 10, 2012, is a holding company. The Company produces and sells premium, super-premium, ultra-premium and luxury wines and other select beverage alcohol products made from wine. Its segment consists of wholesale, direct to consumer and internet. Its wholesale segment includes its retail brand label model and four fully owned brands through the three-tier distribution system. Its direct to consumer segment includes its brands occurring through its tasting rooms and wine clubs. Its internet segment includes sales, which occur through Wine Spies and principally consist of brands not owned by the Company. It also purchases semi-finished bulk wine and finished goods from both foreign and domestic producers. Its wines include Pinot Noir, Chardonnay, Sauvignon Blanc, Zinfandel, Petite Sirah, Merlot, and Cabernet Sauvignon and are sold across a various price points via three distinct distribution channels: three-tier, direct to consumer and Internet. Its Wine sales in the three-tier channel are sold to distributors with programs available to the broad market or to specific retailers on an exclusive basis.

The Company sells its wine under various categories, such as premium ($12-$14 per bottle retail price), super-premium ($15-$24 per bottle retail price), ultra-premium ($25-$49 per bottle retail price) and luxury ($50+ per bottle retail price). It offers its products under various brands, including Truett Hurst, VML, Bradford Mountain, Healdsburg Ranches, The Criminal, Dearly Beloved, Sauvignon Republic, Mad Duck, California Square and Colby Red. It operates two wineries where wine is produced from a range of grapes. Its VML winery, which is a leased facility, can crush, ferment and oak barrel age approximately 500 tons (35,000 cases) of ultra-premium grapes annually, with capacity to increase to 2,000 tons.

The Company competes with Constellation Brands, Inc., E.&J. Gallo Winery, Bronco Wines, Winery Exchange Inc., Vintage Wine Estates, De! licato Family Vineyards and Diageo plc.

Advisors’ Opinion:

  • [By Logan Wallace]

    Media coverage about Truett-Hurst (NASDAQ:THST) has trended somewhat positive on Tuesday, Accern Sentiment reports. The research firm identifies positive and negative news coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Truett-Hurst earned a daily sentiment score of 0.19 on Accern’s scale. Accern also assigned media coverage about the company an impact score of 45.6772286424113 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

  • [By Max Byerly]

    Press coverage about Truett-Hurst (NASDAQ:THST) has trended somewhat positive this week, Accern Sentiment reports. Accern identifies negative and positive media coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Truett-Hurst earned a coverage optimism score of 0.19 on Accern’s scale. Accern also gave media headlines about the company an impact score of 45.6772286424113 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

  • [By Joseph Griffin]

    Media coverage about Truett-Hurst (NASDAQ:THST) has been trending somewhat positive this week, Accern Sentiment reports. The research firm ranks the sentiment of news coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Truett-Hurst earned a daily sentiment score of 0.00 on Accern’s scale. Accern also assigned news headlines about the company an impact score of 44.6844029134937 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.

Hot Blue Chip Stocks To Own For 2022: Ventas, Inc.(VTR)

Ventas, Inc. is a publicly owned real estate investment trust. The firm engages in investment, management, financing, and leasing of properties in the healthcare industry. It invests in the real estate markets of the United States and Canada. The firm primarily invests in healthcare-related facilities including hospitals, skilled nursing facilities, senior housing facilities, medical office buildings, and other healthcare related facilities. Ventas, Inc. was founded in 1983 and is based in Chicago, Illinois with additional offices in Irvine, California; Louisville, Kentucky; Charlotte, North Carolina; and Dallas, Texas.

Advisors’ Opinion:

  • [By Joseph Griffin]

    CIBC Asset Management Inc trimmed its position in Ventas, Inc. (NYSE:VTR) by 1.8% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 71,404 shares of the real estate investment trust’s stock after selling 1,306 shares during the period. CIBC Asset Management Inc’s holdings in Ventas were worth $4,184,000 as of its most recent SEC filing.

  • [By Max Byerly]

    Mackenzie Financial Corp grew its holdings in shares of Ventas, Inc. (NYSE:VTR) by 30.1% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 14,579 shares of the real estate investment trust’s stock after buying an additional 3,371 shares during the quarter. Mackenzie Financial Corp’s holdings in Ventas were worth $854,000 at the end of the most recent reporting period.

  • [By Reuben Gregg Brewer]

    HCP (NYSE:HCP) and Physicians Realty Trust (NYSE:DOC) both advanced roughly 13%, while Omega Healthcare Investors (NYSE:OHI) jumped a little over 14%. Ventas (NYSE:VTR) and Welltower (NYSE:WELL) joined the party, too, up 10% and 11%, respectively.

Hot Blue Chip Stocks To Own For 2022: Bovie Medical Corporation(BVX)

Bovie Medical Corporation, a medical device company, develops, manufactures, and markets electrosurgical devices and related medical products used in doctor’s offices, surgery centers, and hospitals worldwide. The company provides electrosurgical products, including desiccators, generators, electrodes, electrosurgical pencils, and various ancillary disposable products used during surgical procedures in gynecology, urology, plastic surgery, dermatology, veterinary, and other surgical markets for the cutting and coagulation of tissue. It also offers electrosurgical disposables comprising Resistick II, a proprietary coating applied to stainless steel that resist eschar during surgery; and disposable laparoscopic electrodes for use by physicians from a group of specialties, including gynecology, general surgery, and urology. In addition, the company provides battery operated cauteries for precise hemostasis in ophthalmology; specialty lighting instruments for use in ophthalmology, as well as distributes specialty lighting instruments for general surgery, hip replacement surgery, and endotracheal tubes placement; penlights used in physician offices; and a nerve locator stimulator primarily used for identifying motor nerves in hand and facial reconstructive surgery. Further, it develops J-Plasma, a patented helium-based plasma surgical product, as well as designs, develops, and manufactures electrosurgical equipment by producing equipment for medical device manufacturers through original equipment manufacturing agreements. Bovie Medical Corporation markets its products through own brands, such as Bovie, IDS, and ICON, as well as on a private label basis to distributors. The company was formerly known as An-Con Genetics Inc. and changed its name to Bovie Medical Corporation in October 1998. Bovie Medical Corporation was incorporated in 1982 and is headquartered in Clearwater, Florida.

Advisors’ Opinion:

  • [By Motley Fool Transcribers]

    Bovie Medical Corp (NYSEMKT:BVX)Q42018 Earnings Conference CallMarch 13, 2019, 4:30 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Ethan Ryder]

    TheStreet upgraded shares of Bovie Medical (NYSEAMERICAN:BVX) from a d rating to a c- rating in a research report report published on Monday morning.

  • [By Lisa Levin] Gainers
    Red Violet, Inc. (NASDAQ: RDVT) rose 75.31 percent to close at $9.94 after reporting Q1 results.
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares jumped 40.62 percent to close at $4.50 on Tuesday after reporting 2017 year-end results.
    MEI Pharma, Inc. (NASDAQ: MEIP) gained 34.39 percent to close at $3.40.
    MEDIGUS Ltd/S ADR (NASDAQ: MDGS) gained 32.74 percent to close at $1.50 in reaction to its Monday announcement of a distribution agreement. The medical device company said it reached an agreement to distribute its minimally invasive medical devices in Turkey, Azerbaijan and Georgia.
    Pfenex Inc. (NYSE: PFNX) surged 31.15 percent to close at $8.00 after the company announced the positive top-line PF708 study results in Osteoporosis patients that showed no imbalances in severity or incidence of adverse events.
    Arcadia Biosciences, Inc. (NASDAQ: RKDA) rose 21.07 percent to close at $11.09. Arcadia Biosciences reported that Albert D. Bolles, Ph.D. has joined its board of directors.
    Genprex, Inc. (NASDAQ: GNPX) rose 20.23 percent to close at $10.58.
    Turtle Beach Corporation (NASDAQ: HEAR) shares gained 17.62 percent to close at $17.82.
    Aptevo Therapeutics Inc. (NASDAQ: APVO) rose 17.1 percent to close at $5.82.
    Phoenix New Media Limited (NYSE: FENG) shares jumped 16.23 percent to close at $4.87 following Q1 earnings.
    Stein Mart, Inc. (NASDAQ: SMRT) rose 16.04 percent to close at $3.69.
    PPDAI Group Inc. (NASDAQ: PPDF) climbed 15.99 percent to close at $7.98 following Q1 results.
    Tyme Technologies, Inc. (NASDAQ: TYME) rose 15.93 percent to close at $3.42.
    LiqTech International, Inc. (NASDAQ: LIQT) gained 15.59 percent to close at $0.5532 following Q1 results.
    Sophiris Bio, Inc. (NASDAQ: SPHS) gained 13.92 percent to close at $3.52 on Tuesday following Q1 results.
    Euroseas Ltd. (NASDAQ: ESEA) jumped 13.4 percent to close at $2.37.
    Iteris, Inc. (NASDAQ: ITI) shares surged 13.05 percent to close
  • [By Lisa Levin] Gainers
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares climbed 70.3 percent to $5.45 after reporting 2017 year-end results.
    MEDIGUS Ltd/S ADR (NASDAQ: MDGS) surged 39.8 percent to $1.58 in reaction to its Monday announcement of a distribution agreement. The medical device company said it reached an agreement to distribute its minimally invasive medical devices in Turkey, Azerbaijan and Georgia.
    Arcadia Biosciences, Inc. (NASDAQ: RKDA) gained 25.6 percent to $11.50. Arcadia Biosciences reported that Albert D. Bolles, Ph.D. has joined its board of directors.
    Aytu Bioscience Inc (NASDAQ: AYTU) shares jumped 21.8 percent to $0.4798 after the company late Monday reported lighter-than-expected Q1 loss.
    Hollysys Automation Technologies Ltd. (NASDAQ: HOLI) shares gained 21.1 percent to $26.77 following Q3 results.
    Pfenex Inc. (NYSE: PFNX) rose 16.8 percent to $7.1271 after the company announced the positive top-line PF708 study results in Osteoporosis patients that showed no imbalances in severity or incidence of adverse events.
    MEI Pharma, Inc. (NASDAQ: MEIP) rose 13.8 percent to $2.88.
    Red Violet, Inc. (NASDAQ: RDVT) jumped 13.1 percent to $6.41 after reporting Q1 results.
    SORL Auto Parts, Inc. (NASDAQ: SORL) shares gained 12 percent to $5.87 after reporting upbeat Q1 results.
    Bovie Medical Corporation (NYSE: BVX) gained 8.4 percent to $3.96 after reporting a first-quarter sales beat.
    Rosehill Resources Inc. (NASDAQ: ROSE) surged 8.4 percent to $7.90 after announcing Q1 results.
    LiqTech International, Inc. (NASDAQ: LIQT) rose 8.1 percent to $0.5171 following Q1 results.
    ProPhase Labs, Inc. (NASDAQ: PRPH) rose 7.7 percent to $5.6103 following Q1 results.
    Nine Energy Service, Inc. (NYSE: NINE) shares climbed 7.4 percent to $35.90.
    Xenon Pharmaceuticals Inc. (NASDAQ: XENE) rose 6.7 percent to $6.40 after the company presented XEN901 Phase 1 clinical update and XEN1101 TMS pharmacodynamic Phase 1 data.
    MYnd

Hot Blue Chip Stocks To Own For 2022: Stratus Properties Inc.(STRS)

Stratus Properties Inc. engages in the acquisition, development, management, operation, and sale of commercial, hotel, entertainment, and multi-family and single-family residential real estate properties located primarily in the Austin, Texas area. It operates the W Austin Hotel & Residences project located on a 2-acre city block in downtown Austin; and residential real estate properties, including developed, under development, and undeveloped properties in the Barton Creek community, the Circle C community and Lantana, and the condominium units at the W Austin Hotel & Residences project. The company also engages in the leasing of commercial properties comprising two office buildings at 7500 Rialto Boulevard; office and retail space at the W Austin Hotel & Residences project; and a retail building and a bank building in the Barton Creek Village, as well as two retail buildings, including a bank building and the Parkside Village project in the Circle C community. Stratus Pr operties Inc. was founded in 1992 and is headquartered in Austin, Texas.

Advisors’ Opinion:

  • [By Shane Hupp]

    Here are some of the media stories that may have impacted Accern Sentiment’s analysis:

    Get Stratus Properties alerts:

    Analyzing Stratus Properties (STRS) & City Developments (CDEVY) (americanbankingnews.com) Stratus Properties (STRS) versus City Developments (CDEVY) Financial Survey (americanbankingnews.com) Reviewing Stratus Properties (STRS) and St. Joe (JOE) (americanbankingnews.com) Stratus Properties (STRS) versus City Developments (CDEVY) Head-To-Head Analysis (americanbankingnews.com) Contrasting Stratus Properties (STRS) & St. Joe (JOE) (americanbankingnews.com)

    NASDAQ STRS traded down $0.25 during trading hours on Monday, hitting $31.10. The company’s stock had a trading volume of 528 shares, compared to its average volume of 7,123. Stratus Properties has a 52 week low of $26.15 and a 52 week high of $32.15. The company has a quick ratio of 1.09, a current ratio of 1.09 and a debt-to-equity ratio of 1.74.

Hot Blue Chip Stocks To Own For 2022: Vera Bradley Inc.(VRA)

Vera Bradley, Inc., through its subsidiary, Vera Bradley Designs, Inc., engages in the design, production, marketing, and retail of functional accessories for women under the ?Vera Bradley? brand. Its products include a range of handbags, accessories, and travel and leisure items. The company sells its products to independent retailers located in the United States, as well as to national retailers and third party e-commerce sites. As of January 29, 2011, Vera Bradley, Inc. sold its products directly through 35 full-price stores, 4 outlet stores, verabradley.com, and an annual outlet sale in Fort Wayne, Indiana. The company was founded in 1982 and is headquartered in Fort Wayne, Indiana.

Advisors’ Opinion:

  • [By Steve Symington]

    As for individual stocks, Aurora Cannabis (NYSE:ACB) popped after bringing on a promising new strategic advisor, while Vera Bradley (NASDAQ:VRA) soared on a strong quarterly report.

  • [By Garrett Baldwin]

    THREE STOCKS: Any one of these cannabis companies could potentially deliver a 1,000% windfall. Click here to learn more…

    Finally, oil prices pushed higher Wednesday thanks to a dip in exports out of Saudi Arabia and Venezuela. As we’ve noted, the Saudi government is looking to press crude prices higher by reducing OPEC output and limiting shipments to Asia. Those cuts come as economic sanctions continue to weigh on the Venezuelan oil market. The United States imported 500,000 barrels of Venezuelan crude in November 2018, but sanctions will dry up that flow of oil to the United States. With oil prices set to rise in the coming months, we’ve identified the top energy stock to buy in March. Best of all, it’s under $10 per share.
    Stocks to Watch Today: EXPR, BA, TSLA
    Shares of Express Inc. (NASDAQ: EXPR) are off more than 13% this morning after the retail firm issued extremely weak guidance before the bell Wednesday. Although the retail firm topped EPS estimates, it reported a 6% drop in same-store sales to complement a decline in revenue. The firm called its earnings report “disappointing” and listed a series of other challenges that face the company in 2019. Just don’t buy the stock. Shares of Boeing Co.(NYSE: BA) were off in pre-market hours as the global aviation giant continued to reel from last weekend’s Ethiopia Air crash. Countries around the globe are grounding Boeing Air MAX 9 jets until further maintenance and updates are provided by the company. China, Australia, Indonesia, and the European Union have grounded Air 737 MAX 8 flights, and investors are worried that the second crash in five months for one of these planes will cause a delay in orders. BA stock is off 11% in the last two days. Shares of Tesla Inc. (NASDAQ: TSLA) were off in pre-market hours thanks to a negative investor report from Goldman Sachs Group Inc. (NYSE: GS). Goldman issued a “Sell” rating for the stock and projected a weaker price for TSLA stock over concerns about fa

  • [By Timothy Green]

    Shares of Vera Bradley (NASDAQ:VRA) soared on Wednesday following a fourth-quarter report that beat expectations. The fashion specialist’s revenue and earnings came in ahead of analyst estimates, and its full-year guidance was better than expected. As of 11:55 a.m. EDT, the stock was up about 19.9%.